The Carbon Footprint Study of Colonoscopy

ConditionColonoscopy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorKing Chulalongkorn Memorial Hospital

About this trial

With global warming intensifying, GI endoscopy is among the top three greenhouse gas-emitting medical procedures. Colonoscopy, a cornerstone for colorectal cancer (CRC) screening, significantly contributes to the carbon footprint (CF). This study quantifies CO₂ emissions in different steps of colonoscopy and evaluates the environmental impact of common polypectomy techniques to establish baseline CF data and identify opportunities for mitigation. This study included patients undergoing colonoscopy for CRC screening. CO₂ emissions were comprehensively measured at each step of the procedure (pre-, during, and post-colonoscopy), including energy consumption, all equipment and medications, waste management, and endoscopy reprocessing. Emission data were also collected for common polypectomy techniques, including cold forceps biopsy (CFB), cold snare polypectomy (CSP), hot snare polypectomy (HSP), and hot snare endoscopic mucosal resection (EMR), all performed according to standard polypectomy protocols.

Eligibility criteria

Qualifiers

Patients aged 18-80 years

Disqualifiers

Patient status grade III-V according to the American Society of Anesthesiologists (ASA)

Poor bowel preparation (grade <6 in the Boston Bowel Preparation Scale [BBPS])

Endoscopic JNET type III or suspicion of malignancy

Hematologic or coagulation disorders, Plt<140,000/mcL, INR>1.5

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

150 Participants
are grouped into 2 trial groups